VTRS earnings date and last-quarter result: last quarter beat, P/E -64.46. Updated 2026-07-23.
Viatris (VTRS) Research Hub
Viatris (VTRS) trades on NASDAQ, US in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-10-26, shares last closed at 18.29 USD (+1.61%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -64.46, market cap 20.12B. This hub links to the full technical, earnings and options research available for VTRS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 18.29 USD (+1.61%) |
| 52-week range | 15.07 USD – 18.75 USD |
| Trend regime | Range |
| 14-day RSI | 59.7 (Bullish) |
| Trailing P/E | -64.46 |
| Market cap | 20.12B |
| Dividend yield | 2.82% |
Available research for VTRS
Covered Call on VTRS: how it works, illustrative setup around the real 18.29 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on VTRS: how it works, illustrative setup around the real 18.29 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on VTRS: how it works, illustrative setup around the real 18.29 USD price, max profit/loss, breakeven and when to use it. Educational.
VTRS technical analysis: range, last 18.29 USD, RSI 59.7, 52w range 15.07 USD–18.75 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is VTRS in?
Viatris (VTRS) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, US.
Is VTRS in an uptrend or downtrend?
As of 2026-10-26, VTRS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is VTRS's trailing P/E ratio?
VTRS's trailing P/E is -64.46, with a market cap of 20.12B. See the earnings research page for full valuation detail.